17 Capital Partners’s Amgen AMGN Stock Holding History

17 Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.77M	Sell	5,042 -33	-0.7%	-$11.8K	0.91%	17
2025 Q4	$1.66M	Sell	5,075 -17	-0.3%	-$5.39K	0.86%	23
2025 Q3	$1.44M	Sell	5,092 -30	-0.6%	-$8.7K	0.78%	30
2025 Q2	$1.43M	Sell	5,122 -553	-10%	-$157K	0.83%	30
2025 Q1	$1.77M	Hold	5,675	–	–	1.13%	16
2024 Q4	$1.48M	Hold	5,675	–	–	0.94%	29
2024 Q3	$1.83M	Hold	5,675	–	–	1.19%	13
2024 Q2	$1.77M	Sell	5,675 -401	-7%	-$118K	1.26%	15
2024 Q1	$1.73M	Sell	6,076 -4,123	-40%	-$1.21M	1.28%	18
2023 Q4	$2.06M	Buy	+10,199	New	+$2.78M	1.9%	10
2022 Q3	$1.38M	Sell	6,103 -17	-0.3%	-$4.12K	1.88%	8
2022 Q2	$1.49M	Sell	6,120 -24	-0.4%	-$5.88K	1.88%	7
2022 Q1	$1.49M	Buy	6,144 +80	+1%	+$18.4K	1.55%	16
2021 Q4	$1.36M	Sell	6,064 -316	-5%	-$66.7K	1.24%	30
2021 Q3	$1.36M	Buy	6,380 +47	+0.7%	+$10.8K	1.28%	26
2021 Q2	$1.54M	Buy	+6,333	New	+$1.56M	1.43%	17

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

17 Capital Partners's AMGN Position: Q1 2026 in Review

17 Capital Partners reduced its Amgen (AMGN) stake by 0.65% in Q1 2026, selling an estimated $11.8K and leaving 5,042 shares worth $1.77M. The position accounts for 0.91% of the portfolio, ranked #17.

17 Capital Partners first reported a position in AMGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $2.06M in Q4 2023. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

17 Capital Partners held 5,042 shares of Amgen worth $1.77M as of Q1 2026.
17 Capital Partners sold 33 Amgen shares in Q1 2026, an estimated $11.8K.
Amgen made up 0.91% of 17 Capital Partners's portfolio in Q1 2026, its #17 holding.
17 Capital Partners first reported a position in Amgen in Q2 2021 and has held it in 16 quarters since.
17 Capital Partners's Amgen position peaked at $2.06M in Q4 2023.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on 17 Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.